Cardiology Clinical Trials
Heart Failure, LVAD & Heart Transplant ProgramOpens new window
Adult Clinical Trials Main Page
Further protocol information can be found on the links below at ClinicalTrials.gov
Title: Variation in Recovery: Role of Gender on Outcomes of Young Acute Myocardial Infarction (AMI) Patients (VIRGO)
Description: Examining Heart Attacks in Young Women (VIRGO)
Investigator: Fiona Dulbecco, MD
Eligibility: Subjects under the age of 56 who are hospitalized for a heart attack
Status: Active but closed to enrollment
Contact: Jessica Redford, RN, 415-600-1781,
Email: RedforJ@cpmcri.org about Study VIRGO
Title: The HeartMate II LVAS Pivotal Study Protocol, Destination Therapy
Description: Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Destination Therapy
Investigator: Ernest Haeusslein, MD
Eligibility: Subjects with severe congestive heart failure who are not candidates for heart transplant
Status: Active but closed to enrollment
Contact: Jessica Redford, RN, 415-600-1781,
Email: RedforJ@cpmcri.org about Study HeartMate
Title: A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement
Description: The Dual Antiplatelet Therapy Study (DAPT Study)
Investigator: Sung Choi, MD
Eligibility: Subjects >18 years of age undergoing percutaneous intervention with stent deployment
Status: Active but closed to enrollment
Contact: Jessica Redford, RN, 415-600-1781,
Email: RedforJ@cpmcri.org about Study DAPT
Title: A Prospective, Single-Blind, Randomized, Multi-Center Study Comparing the CYPHER® ELITE™ to the CYPHER® Bx VELOCITY® Sirolimus-Eluting Stent Systems (ELITE)
Description: Study Comparing the CYPHER® ELITE™ to the CYPHER® Bx VELOCITY® Sirolimus-Eluting Stent Systems
Investigator: Bruce Brent, MD
Eligibility: Pivotal Study for Subjects with de novo atherosclerotic CAD in 1 or 2 vessels
Status: Active but closed to enrollment
Contact: Jessica Redford, RN, 415-600-1781,
Email: RedforJ@cpmcri.org about Study ELITE
Title: Evaluation of the Safety and Efficacy of the OPTIMIZER System With Active Fixation Leads in Subjects With Heart Failure Resulting From Systolic Dysfunction: FIX-HF-5
Description: Evaluation of the Safety and Effectiveness of the OPTIMIZER System in Subjects With Heart Failure: FIX-HF-5
Investigator: Steven Hao, MD
Eligibility: To evaluate the safety and effectiveness of the Optimizer III System with active fixation leads in subjects with moderate to severe heart failure.
Status: Active but closed to enrollment
Contact: Jessica Redford, RN, 415-600-1781,
Email: RedforJ@cpmcri.org about Study OPTIMIZER
- updated January 2012